• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监测对乳腺癌患者预后的影响。

The effect of surveillance on the outcome of breast cancer patients.

作者信息

Anvari Kazem, Fanipakdel Azar, Davoudi Yasmin

机构信息

Cancer Research Center, Omid Hospital ,Faculty of Medicine, Mashad University of Medical Sciences, Mashad, Iran.

Dept. of Radiology, Imam Reza Hospital, Mashad University of Medical Sciences, Mashad, Iran.

出版信息

Iran J Cancer Prev. 2013 Winter;6(1):17-24.

PMID:25250105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4142908/
Abstract

BACKGROUND

The beginning of metastasis poorly affects the prognosis of breastcancer patients. Lung is the most frequent site of visceral metastasis, and the rate of recurrence is 10-30%. We have tried to find out if the routine Chest X Ray (CXR) could play a role for early detection of lung metastasis, during the prognosis of these patients.

METHODS

The files of the breast cancer patients between 1996 to 2006 (1739 patients) have reviewed. Clinical characteristics of patients with pulmonary metastasis have recorded. Patients, who lacked imaging files or lacked an appropriate follow-up, have excluded. Data have analyzed by SPSS 11.5. The survival analyses have performed by using the Kaplan-Meier method.

RESULTS

Fifty-six patients, median age 46, have entered into this retrospective study. Median tumor size was 4cm; median number of Lymphadenopathy (LAP) was 4. The intermediate grade has detected in 74% of patients. All patients have received adjuvant treatment. Median time from cancer diagnosis to pulmonary metastasis was 22 months. Pulmonary metastasis has detected by control CXR in77.4% and patients' symptoms in 22.6%. Forty eight patients have received chemotherapy in metastatic phase. In 28 patients (50%), other sites of metastasis (bone, liver, and brain) have discovered.The most frequent pattern of lung recurrence was pulmonary nodule (44.6%), followed by pleural effusion (28.6%). Median survival was 27.5; median survival from pulmonary metastasis was 8 m.

CONCLUSION

Early detection of pulmonary metastasis by CXR did not affect patients' endpoints. None of the probable prognostic factors have shown a significant effect on patients' outcome. Despite systemic treatment, survival after metastasis is low.

摘要

背景

转移的发生对乳腺癌患者的预后影响较差。肺是内脏转移最常见的部位,复发率为10% - 30%。我们试图探究在这些患者的预后过程中,常规胸部X线检查(CXR)能否在早期发现肺转移方面发挥作用。

方法

回顾了1996年至2006年间乳腺癌患者的病历(共1739例患者)。记录了肺转移患者的临床特征。排除了缺乏影像资料或缺乏适当随访的患者。数据采用SPSS 11.5进行分析。生存分析采用Kaplan - Meier方法进行。

结果

56例患者进入这项回顾性研究,中位年龄46岁。肿瘤中位大小为4cm;淋巴结病(LAP)中位数量为4个。74%的患者检测为中级。所有患者均接受了辅助治疗。从癌症诊断到肺转移的中位时间为22个月。通过对照CXR检测到肺转移的患者占77.4%,通过患者症状检测到的占22.6%。48例患者在转移期接受了化疗。在28例患者(50%)中,发现了其他转移部位(骨、肝和脑)。最常见的肺复发模式是肺结节(44.6%),其次是胸腔积液(28.6%)。中位生存期为27.5个月;从肺转移开始的中位生存期为8个月。

结论

通过CXR早期发现肺转移并未影响患者的终点指标。没有一个可能的预后因素对患者的结局显示出显著影响。尽管进行了全身治疗,但转移后的生存率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/299262e74100/IJCP-06-017f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/793a3cf76bae/IJCP-06-017f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/33c8fbc66b31/IJCP-06-017f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/fcd1519d4f91/IJCP-06-017f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/475c51a88090/IJCP-06-017f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/076e06820f69/IJCP-06-017f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/31f8ced28853/IJCP-06-017f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/299262e74100/IJCP-06-017f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/793a3cf76bae/IJCP-06-017f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/33c8fbc66b31/IJCP-06-017f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/fcd1519d4f91/IJCP-06-017f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/475c51a88090/IJCP-06-017f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/076e06820f69/IJCP-06-017f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/31f8ced28853/IJCP-06-017f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd9/4142908/299262e74100/IJCP-06-017f7.jpg

相似文献

1
The effect of surveillance on the outcome of breast cancer patients.监测对乳腺癌患者预后的影响。
Iran J Cancer Prev. 2013 Winter;6(1):17-24.
2
Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.新发 IV 期三阴性乳腺癌中特定部位转移和手术的预后价值:基于人群的分析。
Med Sci Monit. 2020 Feb 11;26:e920432. doi: 10.12659/MSM.920432.
3
[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].[晚期三阴性乳腺癌患者的治疗结果及临床病理特征]
Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4.
4
Role of chest radiography in the diagnosis and follow-up of pulmonary metastasis in differentiated thyroid cancer.胸部X线摄影在分化型甲状腺癌肺转移诊断及随访中的作用
J Med Assoc Thai. 2010 Mar;93 Suppl 3:S52-60.
5
Routine chest X-rays have no additional value in the detection of relapse during routine follow-up of patients treated with chemotherapy for disseminated non-seminomatous testicular cancer.对于接受化疗的播散性非精原细胞瘤性睾丸癌患者进行常规随访时,常规胸部X光检查在检测复发方面没有额外价值。
Ann Oncol. 2002 Oct;13(10):1616-20. doi: 10.1093/annonc/mdf282.
6
Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.420例发生中枢神经系统转移的转移性乳腺癌患者的临床病理特征及预后因素
Cancer. 2007 Dec 15;110(12):2640-7. doi: 10.1002/cncr.23088.
7
Overview of resistance to systemic therapy in patients with breast cancer.乳腺癌患者全身治疗耐药概述。
Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1.
8
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.IV 期乳腺癌不同转移部位患者的临床病理特征和生存结局。
BMC Cancer. 2019 Nov 12;19(1):1091. doi: 10.1186/s12885-019-6311-z.
9
New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.激素受体阳性、HER2 阴性乳腺癌患者首发转移部位对生存影响的新认识:271 例患者的多中心研究。
BMC Cancer. 2021 Apr 29;21(1):476. doi: 10.1186/s12885-021-08219-3.
10
Lung metastases in metastatic gastric cancer: pattern of lung metastases and clinical outcome.转移性胃癌的肺转移:肺转移模式和临床结局。
Gastric Cancer. 2012 Jul;15(3):292-8. doi: 10.1007/s10120-011-0104-7. Epub 2011 Oct 29.

本文引用的文献

1
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.原发性乳腺癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v9-14. doi: 10.1093/annonc/mdq159.
2
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?确诊性肿瘤活检会改变伴有远处转移的乳腺癌患者的治疗方式吗?
Ann Oncol. 2009 Sep;20(9):1499-1504. doi: 10.1093/annonc/mdp028. Epub 2009 Mar 18.
3
The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer.
早期乳腺癌中经放射学检测出的无症状肺结节的临床意义。
Ann Oncol. 2008 Dec;19(12):2001-6. doi: 10.1093/annonc/mdn421. Epub 2008 Jul 17.
4
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
5
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.美国临床肿瘤学会2006年辅助性乳腺癌随访与管理指南更新版。
J Clin Oncol. 2006 Nov 1;24(31):5091-7. doi: 10.1200/JCO.2006.08.8575. Epub 2006 Oct 10.
6
Doc, shouldn't we be getting some tests?医生,我们难道不应该做些检查吗?
J Clin Oncol. 2003 May 1;21(9 Suppl):108s-111s. doi: 10.1200/JCO.2003.01.190.
7
[Complete resection of isolated lung metastasis from breast carcinoma results in a strong increase in survival].[乳腺癌孤立性肺转移灶的完全切除可显著提高生存率]
Minerva Chir. 2000 Mar;55(3):121-7.
8
Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators.随访检测对乳腺癌患者生存及健康相关生活质量的影响。一项多中心随机对照试验。GIVIO研究人员。
JAMA. 1994 May 25;271(20):1587-92. doi: 10.1001/jama.1994.03510440047031.
9
Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up.原发性乳腺癌治疗后的强化诊断随访。一项随机试验。国家研究委员会乳腺癌随访项目。
JAMA. 1994 May 25;271(20):1593-7. doi: 10.1001/jama.271.20.1593.
10
Management of malignant pleural effusions.恶性胸腔积液的管理
Chest. 1993 Apr;103(4 Suppl):385S-389S. doi: 10.1378/chest.103.4_supplement.385s.